Lv3
218 积分 2022-08-09 加入
Fifty years of monoclonals: the past, present and future of antibody therapeutics
11天前
已完结
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
1个月前
已完结
Targeting Glycoprotein NMB With Antibody‐Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma
1个月前
已完结
Global conformational changes in IgG-Fc upon mutation of the FcRn-binding site are not associated with altered antibody-dependent effector functions
1个月前
已完结
Exploiting senescence for the treatment of cancer
4个月前
已完结
皖公网安备34019202002308
